B. F. Thomas

Synthetic peripherally-restricted cannabinoid suppresses chemotherapy-induced peripheral neuropathy pain symptoms by CB1 receptor activation.

E. Hirt, H. Seltzman, A. Gilliam, 2016 .

Conformationally constrained analogues of N-(piperidinyl)-5-(4-chlorophenyl)-1-(2,4- dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716): design, synthesis, computational analysis, and biological evaluations.

S. Mascarella, B. Thomas, M. Brackeen, 2008, Journal of medicinal chemistry.

Stratification of Cannabinoid 1 Receptor (CB1R) Agonist Efficacy: Manipulation of CB1R Density through Use of Transgenic Mice Reveals Congruence between In Vivo and In Vitro Assays

D. Selley, A. Lichtman, J. Wiley, 2016, The Journal of Pharmacology and Experimental Therapeutics.